Portfolio company
Voyant Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Voyant Bio develops a spatial intelligence atlas of immune cell interactions to design precision immunotherapies for cancer patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
KANVAS
This company develops spatial biology imaging technology and microbiome-based therapeutics for healthcare providers treating cancer and infectious diseases.
MultivisionDx
This company develops AI-powered spatial biology platforms and diagnostic tests for clinicians and researchers to improve treatment decisions for solid cancer patients.
Cartography
This precision immunotherapy company develops targeted cancer therapies and an antigen atlas for medical researchers to identify cell-specific treatment targets.
Waypoint Bio
This company develops cell therapies for solid tumours using a spatial biology and machine learning platform to assist patients with difficult-to-treat cancers.
Elephas Biosciences
This company develops a live tissue platform for predicting immunotherapy response to assist oncologists, researchers, and pharmaceutical developers in cancer treatment.
Omniscope
Omniscope develops an immune intelligence platform for individuals, clinicians and researchers to track immune system health, disease drivers and cellular aging over time.
Elephas
Elephas develops a live-tissue imaging platform to predict immunotherapy response for clinicians, researchers, and pharmaceutical companies by profiling live tumor biopsies ex vivo.
Aperture Bio
The company develops a single-cell proteomics and spatial profiling platform for drug developers and researchers to analyse oncology drug response in human biology.
